First-trimester nasal bone evaluation for aneuploidy in the general population

Fergal D. Malone, Robert H. Ball, David A. Nyberg, Christine H. Comstock, George Saade, Richard L. Berkowitz, Lorraine Dugoff, Sabrina D. Craigo, Stephen R. Carr, Honor M. Wolfe, Tara Tripp, Mary E. D'Alton

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate the role of fetal nasal bone imaging at 10 3/7 to 13 6/7 weeks as a screening tool for aneuploidy, in a prospective multicenter trial. METHODS: Unselected patients from the general population with viable singleton pregnancies at 10 3/7 to 13 6/7 weeks were recruited at 15 U.S. centers. All had screening with nuchal translucency (NT) ultrasound by specially trained sonographers. In the last 8 months of this trial, first trimester nasal bone evaluation was added to the screening protocol. Nasal bones were described as present, absent, or unable to determine. RESULTS: A total of 38,189 patients completed first trimester NT screening, of whom 6,324 also underwent nasal bone sonography. An acceptable nasal image was obtained in 4,801 cases (76%), with nasal bones described as present in 4,779 (99.5%), and absent in 22 (0.5%). There were 11 identified cases of trisomy-21 in the population of 6,324 patients. In 9 of the 11 cases (82%) the nasal bones were described as present, and 2 cases were described as unable to determine. The only other aneuploidies were 2 cases of trisomy-18, in 1 of which the nasal bones were described as absent, and in 1 present. Absence of nasal bones had sensitivity for aneuploidy of 7.7%, false-positive rate 0.3%, and positive predictive value 4.5%. CONCLUSION: First-trimester nasal bone evaluation was not a useful test for population screening for trisomy-21 and added little to first-trimester NT screening. The difficulty in performing first-trimester nasal bone sonography consistently, in the general population setting, will significantly limit the usefulness of this aneuploidy screening technique.

Original languageEnglish (US)
Pages (from-to)1222-1228
Number of pages7
JournalObstetrics and Gynecology
Volume104
Issue number6
DOIs
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Nasal Bone
Aneuploidy
First Pregnancy Trimester
Nuchal Translucency Measurement
Population
Down Syndrome
Ultrasonography
Nose
Multicenter Studies

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Malone, F. D., Ball, R. H., Nyberg, D. A., Comstock, C. H., Saade, G., Berkowitz, R. L., ... D'Alton, M. E. (2004). First-trimester nasal bone evaluation for aneuploidy in the general population. Obstetrics and Gynecology, 104(6), 1222-1228. https://doi.org/10.1097/01.AOG.0000143255.46196.7a

First-trimester nasal bone evaluation for aneuploidy in the general population. / Malone, Fergal D.; Ball, Robert H.; Nyberg, David A.; Comstock, Christine H.; Saade, George; Berkowitz, Richard L.; Dugoff, Lorraine; Craigo, Sabrina D.; Carr, Stephen R.; Wolfe, Honor M.; Tripp, Tara; D'Alton, Mary E.

In: Obstetrics and Gynecology, Vol. 104, No. 6, 12.2004, p. 1222-1228.

Research output: Contribution to journalArticle

Malone, FD, Ball, RH, Nyberg, DA, Comstock, CH, Saade, G, Berkowitz, RL, Dugoff, L, Craigo, SD, Carr, SR, Wolfe, HM, Tripp, T & D'Alton, ME 2004, 'First-trimester nasal bone evaluation for aneuploidy in the general population', Obstetrics and Gynecology, vol. 104, no. 6, pp. 1222-1228. https://doi.org/10.1097/01.AOG.0000143255.46196.7a
Malone, Fergal D. ; Ball, Robert H. ; Nyberg, David A. ; Comstock, Christine H. ; Saade, George ; Berkowitz, Richard L. ; Dugoff, Lorraine ; Craigo, Sabrina D. ; Carr, Stephen R. ; Wolfe, Honor M. ; Tripp, Tara ; D'Alton, Mary E. / First-trimester nasal bone evaluation for aneuploidy in the general population. In: Obstetrics and Gynecology. 2004 ; Vol. 104, No. 6. pp. 1222-1228.
@article{a4f37dfd906c4c58b173f5379c6edd47,
title = "First-trimester nasal bone evaluation for aneuploidy in the general population",
abstract = "OBJECTIVE: To evaluate the role of fetal nasal bone imaging at 10 3/7 to 13 6/7 weeks as a screening tool for aneuploidy, in a prospective multicenter trial. METHODS: Unselected patients from the general population with viable singleton pregnancies at 10 3/7 to 13 6/7 weeks were recruited at 15 U.S. centers. All had screening with nuchal translucency (NT) ultrasound by specially trained sonographers. In the last 8 months of this trial, first trimester nasal bone evaluation was added to the screening protocol. Nasal bones were described as present, absent, or unable to determine. RESULTS: A total of 38,189 patients completed first trimester NT screening, of whom 6,324 also underwent nasal bone sonography. An acceptable nasal image was obtained in 4,801 cases (76{\%}), with nasal bones described as present in 4,779 (99.5{\%}), and absent in 22 (0.5{\%}). There were 11 identified cases of trisomy-21 in the population of 6,324 patients. In 9 of the 11 cases (82{\%}) the nasal bones were described as present, and 2 cases were described as unable to determine. The only other aneuploidies were 2 cases of trisomy-18, in 1 of which the nasal bones were described as absent, and in 1 present. Absence of nasal bones had sensitivity for aneuploidy of 7.7{\%}, false-positive rate 0.3{\%}, and positive predictive value 4.5{\%}. CONCLUSION: First-trimester nasal bone evaluation was not a useful test for population screening for trisomy-21 and added little to first-trimester NT screening. The difficulty in performing first-trimester nasal bone sonography consistently, in the general population setting, will significantly limit the usefulness of this aneuploidy screening technique.",
author = "Malone, {Fergal D.} and Ball, {Robert H.} and Nyberg, {David A.} and Comstock, {Christine H.} and George Saade and Berkowitz, {Richard L.} and Lorraine Dugoff and Craigo, {Sabrina D.} and Carr, {Stephen R.} and Wolfe, {Honor M.} and Tara Tripp and D'Alton, {Mary E.}",
year = "2004",
month = "12",
doi = "10.1097/01.AOG.0000143255.46196.7a",
language = "English (US)",
volume = "104",
pages = "1222--1228",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - First-trimester nasal bone evaluation for aneuploidy in the general population

AU - Malone, Fergal D.

AU - Ball, Robert H.

AU - Nyberg, David A.

AU - Comstock, Christine H.

AU - Saade, George

AU - Berkowitz, Richard L.

AU - Dugoff, Lorraine

AU - Craigo, Sabrina D.

AU - Carr, Stephen R.

AU - Wolfe, Honor M.

AU - Tripp, Tara

AU - D'Alton, Mary E.

PY - 2004/12

Y1 - 2004/12

N2 - OBJECTIVE: To evaluate the role of fetal nasal bone imaging at 10 3/7 to 13 6/7 weeks as a screening tool for aneuploidy, in a prospective multicenter trial. METHODS: Unselected patients from the general population with viable singleton pregnancies at 10 3/7 to 13 6/7 weeks were recruited at 15 U.S. centers. All had screening with nuchal translucency (NT) ultrasound by specially trained sonographers. In the last 8 months of this trial, first trimester nasal bone evaluation was added to the screening protocol. Nasal bones were described as present, absent, or unable to determine. RESULTS: A total of 38,189 patients completed first trimester NT screening, of whom 6,324 also underwent nasal bone sonography. An acceptable nasal image was obtained in 4,801 cases (76%), with nasal bones described as present in 4,779 (99.5%), and absent in 22 (0.5%). There were 11 identified cases of trisomy-21 in the population of 6,324 patients. In 9 of the 11 cases (82%) the nasal bones were described as present, and 2 cases were described as unable to determine. The only other aneuploidies were 2 cases of trisomy-18, in 1 of which the nasal bones were described as absent, and in 1 present. Absence of nasal bones had sensitivity for aneuploidy of 7.7%, false-positive rate 0.3%, and positive predictive value 4.5%. CONCLUSION: First-trimester nasal bone evaluation was not a useful test for population screening for trisomy-21 and added little to first-trimester NT screening. The difficulty in performing first-trimester nasal bone sonography consistently, in the general population setting, will significantly limit the usefulness of this aneuploidy screening technique.

AB - OBJECTIVE: To evaluate the role of fetal nasal bone imaging at 10 3/7 to 13 6/7 weeks as a screening tool for aneuploidy, in a prospective multicenter trial. METHODS: Unselected patients from the general population with viable singleton pregnancies at 10 3/7 to 13 6/7 weeks were recruited at 15 U.S. centers. All had screening with nuchal translucency (NT) ultrasound by specially trained sonographers. In the last 8 months of this trial, first trimester nasal bone evaluation was added to the screening protocol. Nasal bones were described as present, absent, or unable to determine. RESULTS: A total of 38,189 patients completed first trimester NT screening, of whom 6,324 also underwent nasal bone sonography. An acceptable nasal image was obtained in 4,801 cases (76%), with nasal bones described as present in 4,779 (99.5%), and absent in 22 (0.5%). There were 11 identified cases of trisomy-21 in the population of 6,324 patients. In 9 of the 11 cases (82%) the nasal bones were described as present, and 2 cases were described as unable to determine. The only other aneuploidies were 2 cases of trisomy-18, in 1 of which the nasal bones were described as absent, and in 1 present. Absence of nasal bones had sensitivity for aneuploidy of 7.7%, false-positive rate 0.3%, and positive predictive value 4.5%. CONCLUSION: First-trimester nasal bone evaluation was not a useful test for population screening for trisomy-21 and added little to first-trimester NT screening. The difficulty in performing first-trimester nasal bone sonography consistently, in the general population setting, will significantly limit the usefulness of this aneuploidy screening technique.

UR - http://www.scopus.com/inward/record.url?scp=15944428777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15944428777&partnerID=8YFLogxK

U2 - 10.1097/01.AOG.0000143255.46196.7a

DO - 10.1097/01.AOG.0000143255.46196.7a

M3 - Article

VL - 104

SP - 1222

EP - 1228

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 6

ER -